Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion
Editorial Group: Cochrane Eyes and Vision Group
Published Online: 1 MAY 2014
Assessed as up-to-date: 29 OCT 2013
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
How to Cite
Braithwaite T, Nanji AA, Lindsley K, Greenberg PB. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion. Cochrane Database of Systematic Reviews 2014, Issue 5. Art. No.: CD007325. DOI: 10.1002/14651858.CD007325.pub3.
- Publication Status: New search for studies and content updated (conclusions changed)
- Published Online: 1 MAY 2014
This article has been cited by:
- 1Ocular Toxicity in Metastatic Melanoma Patients Treated With Mitogen-Activated Protein Kinase Kinase Inhibitors: A Case Series, American Journal of Ophthalmology, 2015, 160, 5, 959, , , , , ,
- 2Retinaler Venenverschluss, Der Ophthalmologe, 2015, 112, 8, 695, ,